Adjuvant Olaparib in BRCA-Mutated Breast Cancer

N Engl J Med. 2021 Oct 7;385(15):1439-1440. doi: 10.1056/NEJMc2112373.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Breast Neoplasms* / drug therapy
  • Breast Neoplasms* / genetics
  • Female
  • Humans
  • Phthalazines / therapeutic use
  • Piperazines / therapeutic use

Substances

  • Phthalazines
  • Piperazines
  • olaparib